From: Cardiac retransplantation is an efficacious therapy for primary cardiac allograft failure
Gender (female) | 20% |
---|---|
Race (Caucasian) | 89.4% |
Initial Graft Survival (months) | 62.1 ± 32.6 |
Blood Group | A (60%) |
B (6.7%) | |
AB (0%) | |
O (33.3%) | |
Recipient Body Mass Index (kg/m2) | 27.9 ± 3.7 |
Pre-Operative Creatinine (mg/dl) | 2.5 ± 1.5 |
Chronic Renal Insufficiency (Cr>1.5) | 60.0% |
Diabetes Mellitus | 20.0% |
Hypertension | 66.7% |
Hypercholesterolemia | 53.3% |